His lab is engaged on refining the alanine-scanning assay to a few crucial residues which will properly distinguish in between fibrils from neurodegenerative tauopathies. He envisions working with this streamlined assay for postmortem neuropathological analysis, and possibly for blood screening of tauopathies.Despite these promising innovations, th